Promise Bio
Tel Aviv · Founded 2023
About Promise Bio
Promise Bio is focused on pioneering precision medicine by utilizing epiproteomic analysis to understand autoimmune diseases. The company employs a cloud-based AI platform to perform comprehensive analyses of standard mass-spectrometry data, revealing insights into protein modifications that affect disease mechanisms.
Company Facts
- Founded: 2023
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.3M
- Funding stage: Seed
- Last round: Grant (Dec 2024)
- Website: https://www.promise.bio
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/promise-bio-5426 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.